[Future prospects for specific immunotherapy].
Sugaya
Masakazu
M
Second Department of Surgery, University of Occupational and Environmental Health, Japan.
Takenoyama
Mitsuhiro
M
Yasumoto
Kosei
K
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000951:Antigens, Neoplasm / Q000302:isolation & purification; D019496:Cancer Vaccines / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D016219:Immunotherapy, Adoptive; D008175:Lung Neoplasms / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D000068878:Trastuzumab